Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel dual NADPH oxidase inhibitor shows excellent safety/pharmacokinetic profile

Nov. 14, 2012

sGPVI as a risk marker in inflammatory arthritis

Nov. 14, 2012

Preliminary clinical results presented for FG-4592 in hemodialysis patients

Nov. 14, 2012

Interim results presented for a peptide-based cancer vaccine

Nov. 13, 2012

Promising phase I results presented for myrcludex B

Nov. 13, 2012

Vertex presents in vitro results for a novel CFTR corrector

Nov. 13, 2012

Novel biguanide inhibits cell proliferation and cyst growth of human ADPKD cells

Nov. 13, 2012

Novel biomarker for the diagnosis of ACS presented by Japanese group

Nov. 12, 2012

VS-5584 treatment inhibits cancer stem cells in vitro and in vivo

Nov. 12, 2012

Kowa describes preclinical testing of novel cholesteryl ester transfer protein inhibitor

Nov. 12, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...